Effect of lymphocytapheresis plus cyclophosphamide on the course of a chronic progressive form of multiple sclerosis
✍ Scribed by S. Ferla; G. Meneghetti; S. Spartà; M. Belloni; G. Ongaro
- Publisher
- Springer Milan
- Year
- 1985
- Tongue
- English
- Weight
- 357 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
39 patients with chronic-progressive multiple sclerosis were treated with a short course of intensive immunosuppression in high doses of cyclophosphamide and prednisone. The follow-up period varied between 1 and 5 years with a mean of 21/2 years. Progression of the disease ceased in 27 patients for
OBJECTIVE: To examine the hypothesis that addition of therapeutic plasma exchange (TPEX) to an immunosuppressive drug regimen increases that regimen's efficacy to halt the progression of chronic progressive multiple sclerosis (CPMS). METHODS: The literature was searched for prospective controlled cl
Lymphocytes from 15 of 17 patients with clinically well defined multiple sclerosis (MS) responded to all four MS brain homogenates as assayed by active E rosette test. Lymphocytes from only one neurological patient, out of 18 tested, responded to MS brain homogenates. The nature of the stimulating a